Clinical TrialID 7699
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
NCT04723069
Pelvic Inflammatory Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Formula: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7699
- Evidence Id
- 7699
- Core Evidence Id
- 7699
- Source Clinical Trial Id
- 7697
- Herb2 Clinical Trial Id
- HBCT007697
- Nct Id
- NCT04723069
- Title
- Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Pelvic Inflammatory Disease
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Control Group|DRUG: Test Group
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- Female
- Age
- Adult
- Enrollment
- 198
- Outcome Measure
- Improvement in Visual Analog Scale (VAS) for pain assessment, Applying the Visual Analogue Scale (VAS) i.e. 0-10 Numeric Pain Intensity Scale on a 10 cm line segment the pain will be assessed as 0 is painless, 10 is extremely painful. Patients will mark in the corresponding position according to the degree of pain, and the researcher will give a specific score. The grading criteria of Pelvic pain with VAS score will be, normal: 0 cm; mild: 1-3 cm; moderate: 4-6 cm; severe: 7-10 cm., after 28 days of treatment
- Sponsor Collaborator
- University of Karachi|Zhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China|Center for bioequivalence studies and Clinical Research (CBSCR), ICCBS, University of Karachi
- Funded By
- OTHER
- Location
- Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi, Karachi, 75270, Pakistan
- Other Id
- CRO-007-TCM-FKQJ -2020
- Start Date
- 2021-09-21
- Primary Completion Date
- 2022-03-11
- Completion Date
- 2022-03-11
- First Posted
- 2021-01-25
- Results First Posted
- Last Update Posted
- 2023-04-04
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT04723069
- Title Cn
- Title En
- Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
- Bilingual Status
- semi_complete